Chi­nese de­vel­op­ment group blue­prints $1B-plus biotech cam­pus in South San Fran­cis­co

When re­al es­tate bro­kers land­ed the 42-acre wa­ter­front site known as The Land­ing at Oys­ter Point in South San Fran­cis­co last fall, they oohed and aa­hed about its po­ten­tial as a new biotech cam­pus ly­ing ad­ja­cent to Genen­tech, one of the pi­o­neer­ing founders of the in­dus­try. It al­ready had a 443,000-square-foot busi­ness park in place, with po­ten­tial for hun­dreds of thou­sands of ad­di­tion­al space.

That all proved to be ir­re­sistible to a group of Chi­nese de­vel­op­ers who are now plan­ning to in­vest more than $1 bil­lion in­to the prop­er­ty, with ini­tial plans to add 500,000 square feet of of­fice and lab space for the re­gion’s boom­ing biotech in­dus­try. Tao­tao Song, CEO of Oys­ter Point De­vel­op­ment, LLC, and EVP at Green­land USA, a key play­er in the joint ven­ture de­vel­op­ment group, had this to say:

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER